Display options
Cite
Hoang KV, Adcox HE, Fitch JR, et al. AR-13, a Celecoxib Derivative, Directly Kills . Front Microbiol. 2017;8:1695doi: 10.3389/fmicb.2017.01695.
Hoang, K. V., Adcox, H. E., Fitch, J. R., Gordon, D. M., Curry, H. M., Schlesinger, L. S., White, P., & Gunn, J. S. (2017). AR-13, a Celecoxib Derivative, Directly Kills . Frontiers in microbiology, 81695. https://doi.org/10.3389/fmicb.2017.01695
Hoang, Ky V, et al. "AR-13, a Celecoxib Derivative, Directly Kills ." Frontiers in microbiology vol. 8 (2017): 1695. doi: https://doi.org/10.3389/fmicb.2017.01695
Hoang KV, Adcox HE, Fitch JR, Gordon DM, Curry HM, Schlesinger LS, White P, Gunn JS. AR-13, a Celecoxib Derivative, Directly Kills . Front Microbiol. 2017 Sep 11;8:1695. doi: 10.3389/fmicb.2017.01695. eCollection 2017. PMID: 28955308; PMCID: PMC5600997.
Copy Download .nbib Format: NLM
Share it on

Front Microbiol. 2017 Sep 11;8:1695. doi: 10.3389/fmicb.2017.01695. eCollection 2017.

AR-13, a Celecoxib Derivative, Directly Kills .

Frontiers in microbiology

Ky V Hoang, Haley E Adcox, James R Fitch, David M Gordon, Heather M Curry, Larry S Schlesinger, Peter White, John S Gunn

Affiliations

  1. Center for Microbial Interface Biology, Department of Microbial Infection and Immunity, The Ohio State University, ColumbusOH, United States.
  2. The Institute for Genomic Medicine, Nationwide Children's Hospital, ColumbusOH, United States.
  3. Department of Pediatrics, The Ohio State University College of Medicine, ColumbusOH, United States.

PMID: 28955308 PMCID: PMC5600997 DOI: 10.3389/fmicb.2017.01695

[No abstract available.]

Keywords: AR-13; Francisella; antimicrobials; celecoxib; efflux pump

References

  1. J Med Microbiol. 2008 Aug;57(Pt 8):921-30 - PubMed
  2. Epidemiol Infect. 2015 Jul;143(10):2137-60 - PubMed
  3. Antimicrob Agents Chemother. 2009 Jul;53(7):2998-3002 - PubMed
  4. J Antimicrob Chemother. 2014 Jan;69(1):101-10 - PubMed
  5. Microbiol Mol Biol Rev. 2012 Jun;76(2):383-404 - PubMed
  6. Clin Infect Dis. 1994 Jul;19(1):42-7 - PubMed
  7. Bioorg Med Chem. 2012 Aug 1;20(15):4653-60 - PubMed
  8. J Antimicrob Chemother. 2010 Nov;65(11):2359-67 - PubMed
  9. Infect Dis Clin North Am. 2010 Mar;24(1):43-55 - PubMed
  10. Front Cell Infect Microbiol. 2014 Mar 13;4:35 - PubMed
  11. Scand J Infect Dis. 2013 Sep;45(9):725-7 - PubMed
  12. J Immunol. 2008 Oct 15;181(8):5568-78 - PubMed
  13. FEMS Microbiol Lett. 2008 Feb;279(2):226-33 - PubMed
  14. Euro Surveill. 2014 Jul 24;19(29):null - PubMed
  15. Infect Immun. 2007 Jan;75(1):371-8 - PubMed
  16. Genome Biol. 2015 Jan 20;16:6 - PubMed
  17. BMC Microbiol. 2010 Apr 23;10:123 - PubMed
  18. J Immunol. 1990 Apr 1;144(7):2771-80 - PubMed
  19. Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12897-902 - PubMed
  20. Int J Pharm. 2014 Dec 30;477(1-2):334-43 - PubMed
  21. Clin Infect Dis. 2001 Aug 15;33(4):573-6 - PubMed
  22. ACS Chem Biol. 2011 May 20;6(5):502-10 - PubMed
  23. Clin Infect Dis. 2009 Apr 1;48(7):863-70 - PubMed
  24. Clin Infect Dis. 2004 Mar 15;38(6):864-70 - PubMed
  25. PLoS Pathog. 2014 Mar 06;10(3):e1003984 - PubMed
  26. Balkan Med J. 2014 Mar;31(1):3-10 - PubMed
  27. Antimicrob Agents Chemother. 2004 Dec;48(12):4513-9 - PubMed
  28. Nat Rev Microbiol. 2004 Dec;2(12):967-78 - PubMed
  29. Bioorg Med Chem. 2015 May 1;23(9):1935-43 - PubMed
  30. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2052-62 - PubMed
  31. Infect Immun. 2012 Mar;80(3):1088-97 - PubMed
  32. J Biomed Sci. 2009 Dec 09;16:110 - PubMed
  33. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):1009-14 - PubMed
  34. Front Cell Infect Microbiol. 2012 Mar 16;2:32 - PubMed
  35. Antimicrob Agents Chemother. 2009 Dec;53(12 ):5236-44 - PubMed
  36. Appl Environ Microbiol. 2011 Apr;77(7):2309-16 - PubMed
  37. Front Cell Infect Microbiol. 2014 Mar 28;4:40 - PubMed
  38. Antimicrob Agents Chemother. 2008 Jun;52(6):2276-8 - PubMed
  39. Front Cell Infect Microbiol. 2014 Aug 19;4:115 - PubMed
  40. Emerg Infect Dis. 2006 Jul;12(7):1113-8 - PubMed

Publication Types